机译:MiR-199A通过与CCR7 / CCL21对的相互作用来介导人体地幔细胞淋巴瘤的传播
Zhengzhou Univ Affiliated Hosp 1 Dept Oncol Sci Ave 100 Zhengzhou 450001 Henan Peoples R China;
Zhengzhou Univ Affiliated Hosp 1 Dept Oncol Sci Ave 100 Zhengzhou 450001 Henan Peoples R China;
Zhengzhou Univ Affiliated Hosp 1 Dept Oncol Sci Ave 100 Zhengzhou 450001 Henan Peoples R China;
Zhengzhou Univ Affiliated Hosp 1 Dept Oncol Sci Ave 100 Zhengzhou 450001 Henan Peoples R China;
Zhengzhou Univ Affiliated Hosp 1 Dept Oncol Sci Ave 100 Zhengzhou 450001 Henan Peoples R China;
Zhengzhou Univ Affiliated Hosp 1 Dept Oncol Sci Ave 100 Zhengzhou 450001 Henan Peoples R China;
Zhengzhou Univ Affiliated Hosp 1 Dept Oncol Sci Ave 100 Zhengzhou 450001 Henan Peoples R China;
Zhengzhou Univ Affiliated Hosp 1 Dept Oncol Sci Ave 100 Zhengzhou 450001 Henan Peoples R China;
Zhengzhou Univ Affiliated Hosp 1 Dept Oncol Sci Ave 100 Zhengzhou 450001 Henan Peoples R China;
Zhengzhou Univ Sch Nursing Zhengzhou Henan Peoples R China;
Zhengzhou Univ Affiliated Hosp 1 Dept Oncol Sci Ave 100 Zhengzhou 450001 Henan Peoples R China;
CCL21; C-C chemokine receptor 7; dissemination; invasion; mantle cell lymphoma; miR-199a;
机译:MiR-199A通过与CCR7 / CCL21对的相互作用来介导人体地幔细胞淋巴瘤的传播
机译:抗CCR7疗法在人套细胞淋巴瘤的异种移植模型中发挥有效的抗肿瘤活性
机译:趋化因子受体CCR7对人T细胞淋巴瘤传播行为的影响:临床和实验研究
机译:淋巴细胞作为载体,用于细胞介导的化学治疗纳米颗粒传递至弥漫性淋巴瘤。
机译:弥漫性大B细胞淋巴瘤中的MAP激酶相互作用激酶介导的翻译。
机译:抗CCR7疗法在人套细胞淋巴瘤的异种移植模型中发挥有效的抗肿瘤活性
机译:抗CCR7疗法在人套细胞淋巴瘤的异种移植模型中发挥有效的抗肿瘤活性